CYCLIC COMPOUND AND PPAR AGONIST

Details for Australian Patent Application No. 2002325535 (hide)

Owner EISAI CO., LTD.

Inventors SHINODA, Masanobu; KASAI, Shunji; YOSHITOMI, Hideki; YAMAZAKI, Kazuto; INOUE, Takashi; MIYASHITA, Sadakazu; HIHARA, Taro; CLARK, Richard; MATSUURA, Fumiyoshi; EMORI, Eita

Pub. Number AU-A-2002325535

PCT Number PCT/JP02/08325

PCT Pub. Number WO2003/016265

Priority 2001-247540 17.08.01 JP

Filing date 16 August 2002

Wipo publication date 3 March 2003

International Classifications

C07C 233/87 Carboxylic acid amides

C07C 251/60 Compounds containing nitrogen atoms doubly- bound to a carbon skeleton

C07D 213/53 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 263/32 Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 263/34 Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 277/56 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 307/24 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 307/30 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 317/32 Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 339/08 Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms

C07D 405/06 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 407/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 031/195

A61K 031/341 - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 031/343 - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 031/357 - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 031/385 - having two or more sulfur atoms in the same ring

A61K 031/396 - having three-membered rings, e.g. aziridine

A61K 031/4025 - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 031/421 - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61K 031/422 - not condensed and containing further heterocyclic rings

A61K 031/423 - condensed with carbocyclic rings

A61K 031/426 - 1,3-Thiazoles

A61K 031/427 - not condensed and containing further heterocyclic rings

A61K 031/4402 - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 031/443

A61K 031/4439

A61K 031/4523 - containing further heterocyclic ring systems

A61K 031/4709 - Non-condensed quinolines containing further heterocyclic rings

A61K 031/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 031/497

A61K 031/352 - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61P 001/00 Drugs for disorders of the alimentary tract or the digestive system

A61P 001/04 Drugs for disorders of the alimentary tract or the digestive system

A61P 003/04 Drugs for disorders of the metabolism

A61P 003/06 Drugs for disorders of the metabolism

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 2001-247540 17.08.01 JP

29 May 2003 Application Open to Public Inspection

  Published as AU-A-2002325535

6 May 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002325536-PRINTED BOARD UNIT AND LINKED PRINTED BOARD USING IT, LED DISPLAY UNIT

2002325534-EXAMINATION REQUEST MANAGEMENT APPARATUS